Revista de neurologia
-
Revista de neurologia · Mar 2015
Observational Study[Assessment of the effectiveness and safety of Sativex® in compassionate use].
Sativex® is a drug approved for use in the treatment of spasticity in multiple sclerosis. We sought to study the tolerability and effectiveness of this drug product in pathologies beyond the scope of the indications of the product data sheet, by means of its compassionate use. ⋯ Sativex may be an interesting therapeutic alternative in patients with spasticity and pain when the treatments that are usually available have been employed but patients' quality of life continues to be significantly compromised.